Characteristics of the First 102 Severe COVID-19 Cases Treated With Convalescent Plasma or Tocilizumab or Both in Al-Nahdha Hospital, Oman

• Main Authors: Saud Al Harthi (Author), Magdi Al Osali (Author), Nasser Al Kindi (Author), Zahir Al Kharusi (Author), Salim Al Qasabi (Author), Mohamed Al Hinai (Author), Thamra Al Ghafri (Author)
• Format: Book
• Published: SAGE Publishing, 2021-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: In the absence of an effective vaccine, the coronavirus disease (COVID-19) continues to cause more deaths. Evidence on the effectiveness of various COVID-19 management plans is inconclusive. This paper describes the characteristics of the first 102 severe COVID-19 in-patients treated wit...